Cristina Gasparetto, MD
Department / Division
Medicine /
Medicine - Cell Therapy and Hematologica
Address
DUMC 3961
Durham, NC 27710
Appointment Telephone
919-668-1017
Office Telephone
919-668-1017
Fax Telephone
919-668-1091
- MD, Sapienza University of Rome (Italy), 1986
- Internal Medicine, Duke University Medical Center, 1993-1996
- Hematology and Bone Marrow Transplant, Duke University Medical Center, 1996-1999
Clinical Interests
Patients with hematologic malignancies who could be candidates for high-dose chemotherapy and stem-cell support; multiple myeloma
Research Interests
Dr. Gasparetto performs both laboratory and clinical research in the field of multiple myeloma. Her primary research interests are in developing immunotherapy approaches to treating multiple myeloma particularly in conjunction with hematopoietic stem cell transplantation. Ongoing laboratory research projects include the development of dendritic cell vaccines and antibody therapies. Clinical studies include a recently approved trial involving vaccination with autologous dendritic cells pulsed with idiotypic protein following high dose chemotherapy and autologous peripheral blood stem cells transplant. Upcoming trials include novel antibody therapies for multiple myeloma. Dr. Gasparetto is also an investigator on several other clinical trials for myeloma including non-myeloablative allogeneic transplantation, high dose sequential chemotherapy and autologous peripheral blood stem cell transplantation and transplantation of partially HLA matched unrelated cord blood.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Celgene Corporation
- Millennium Pharmaceuticals, Inc. (Takeda)
- Onyx
